Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche And Bayer To Work With QB3

by Ann M. Thayer
May 27, 2013 | A version of this story appeared in Volume 91, Issue 21

California Institute for Quantitative Biosciences (QB3) has two new corporate partners. Roche and QB3 will identify and fund life sciences start-up companies in the San Francisco Bay Area. Start-ups may emerge from QB3’s local incubator network, its other support programs, or university labs. Meanwhile, QB3 has a new multiyear agreement with Bayer HealthCare to evaluate start-up firms from the QB3 network for potential collaborations. Mission Bay Capital will provide funding to the start-ups. In addition to funding, both Roche and Bayer may contribute scientific expertise and other resources.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.